Results 11 to 20 of about 2,992 (192)

Albúmina glicada. Inhibición por aspirina. [PDF]

open access: yesGaceta Médica Espirituana, 2012
El experimento evaluó “in vitro” la capacidad inhibitoria y protectora de la aspirina sobre el ataque de la glucosa a la albúmina sérica bovina en función del tiempo y de la concentración del fármaco.
Aristides Lázaro Brito Machín   +4 more
doaj   +1 more source

O uso da Aspirina na Prevenção Primária da doença cardiovascular: novas atualizações

open access: yesRevista Brasileira de Medicina de Família e Comunidade, 2011
Muitas vezes os Médicos de Família têm de tomar a decisão de iniciar ou não o uso de aspirina nos seus pacientes. Embora os benefícios do tratamento com aspirina na redução do risco de enfarte do miocárdio (EM), acidente vascular cerebral (AVC) ou morte ...
Luís Filipe Cavadas
doaj   +2 more sources

Long-term efficacy of aspirin desensitization in aspirin-exacerbated respiratory disease. Review of two clinical cases

open access: yesRevista Alergia México, 2016
Background: The aspirin exacerbated respiratory disease (AERD) shows a prevalence of 7% among asthmatics and increases to 14% in patients with difficult to control asthma.
Julio César Cambray-Gutiérrez   +5 more
doaj   +2 more sources

La aspirina es ineficaz en la prevención de la pre-eclampsia [PDF]

open access: yesRevista de la Facultad de Medicina, 1998
Tres recientes estudios han confirmado que la aspirina no aporta ningún beneficio en la prevención de la pre-eclampsia o en reducir los efectos de esta en los recién nacidos.
Carlos Bustamante Rojas
doaj   +1 more source

La aspirina [PDF]

open access: yes, 2000
¿Cómo funciona la aspirina?/ ¿Podría la aspirina ayudar?/ ¿Aspirina para personas sanas?/ ¿La otra cara de la ...
Lores, Antonio José   +1 more
core   +2 more sources

La aspirina en la prevención primaria del cáncer colorrectal

open access: yesAnales del Sistema Sanitario de Navarra, 2012
La Aspirina y otros antiinflamatorios (AINEs) se han asociado a una reducción en el riesgo de desarrollar adenomas y cáncer colorrectal. Con la evidencia científica disponible, queda justificada la necesidad de más estudios que evalúen el efecto ...
M. Fernández Calderón   +1 more
doaj   +2 more sources

Evaluation of the chemopreventive potentials of ezetimibe and aspirin in a novel mouse model of gallbladder preneoplasia

open access: yesMolecular Oncology, Volume 14, Issue 11, Page 2834-2852, November 2020., 2020
A novel mouse model of gallbladder preneoplasia secondary to diet‐induced stones progresses in parallel with intense inflammation. Ezetimibe inhibits stone formation, inflammation, and metaplasia–dysplasia development. Aspirin does not reduce stone formation, however, ameliorates inflammation and preneoplasia onset (but only in a low‐cholesterol diet).
Lorena Rosa   +16 more
wiley   +1 more source

Entry and price competition in the over‐the‐counter drug market after deregulation: Evidence from Portugal

open access: yesHealth Economics, Volume 29, Issue 8, Page 865-877, August 2020., 2020
Abstract In the last two decades, many European countries allowed the sale of over‐the‐counter (OTC) drugs outside pharmacies. This was expected to lower retail prices through increased competition. Evidence of such price reductions is scarce. We assess the impact of supermarket and outlet entry in the OTC drug market on OTC prices charged by incumbent
Ana Moura, Pedro Pita Barros
wiley   +1 more source

Aspirin and blood pressure: Effects when used alone or in combination with antihypertensive drugs

open access: yesRevista Portuguesa de Cardiologia, 2017
Arterial hypertension is a major risk factor for cardiovascular and renal events. Lowering blood pressure is thus an important strategy for reducing morbidity and mortality.
Ana Catarina Costa   +3 more
doaj   +1 more source

Adjuvant statin therapy for oesophageal adenocarcinoma: the STAT‐ROC feasibility study

open access: yesBJS Open, Volume 4, Issue 1, Page 59-70, February 2020., 2020
After oesophagectomy for oesophageal adenocarcinoma (OAC), the 5‐year survival rate is currently only 30 per cent. There is strong observational evidence that statin use is associated with reduced all‐cause and cancer‐specific mortality in patients with OAC.
L. Alexandre   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy